ArticleEndocrine2020
Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism.
Christian Adolf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled ittrialcites it